Roman Gonzenbach
Overview
Explore the profile of Roman Gonzenbach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kupjetz M, Patt N, Joisten N, Ueland P, McCann A, Gonzenbach R, et al.
Int J Tryptophan Res
. 2024 Nov;
17:11786469241284423.
PMID: 39534856
Background: The kynurenine pathway (KP) is an important hub in neuroimmune crosstalk that is dysregulated in persons with multiple sclerosis (pwMS) and modulated by exercise in a modality-specific manner. Objectives:...
2.
Patt N, Kupjetz M, Schlagheck M, Hersche R, Joisten N, Kool J, et al.
Mult Scler Relat Disord
. 2024 Aug;
90:105826.
PMID: 39191095
Background: Symptomatic treatment in people with multiple sclerosis (pwMS) requires multidisciplinary rehabilitation to alleviate disease progression and increasing health-related quality of life (HRQoL). However, the participant- and disease-specific factors that...
3.
Kanzler C, Armand T, Simovic L, Sylvester R, Domnik N, Eilfort A, et al.
J Neuroeng Rehabil
. 2024 Jul;
21(1):125.
PMID: 39068424
Background: Technology-based assessments using 2D virtual reality (VR) environments and goal-directed instrumented tasks can deliver digital health metrics describing upper limb sensorimotor function that are expected to provide sensitive endpoints...
4.
Mylius V, Zenev E, Brook C, Brugger F, Maetzler W, Gonzenbach R, et al.
Brain Sci
. 2024 Jul;
14(7).
PMID: 39061366
Imbalance and falls in patients with Parkinson's disease (PD) do not only reduce their quality of life but also their life expectancy. Aging-related symptoms as well as disease-specific motor and...
5.
Daniore P, Nittas V, Haag C, Bernard J, Gonzenbach R, von Wyl V
NPJ Digit Med
. 2024 Jun;
7(1):161.
PMID: 38890529
Wearable sensor technologies are becoming increasingly relevant in health research, particularly in the context of chronic disease management. They generate real-time health data that can be translated into digital biomarkers,...
6.
Sieber C, Haag C, Polhemus A, Haile S, Sylvester R, Kool J, et al.
JMIR Rehabil Assist Technol
. 2024 Mar;
11:e52733.
PMID: 38498024
Background: Physical activity (PA) represents a low-cost and readily available means of mitigating multiple sclerosis (MS) symptoms and alleviating the disease course. Nevertheless, persons with MS engage in lower levels...
7.
Lu Z, Signer T, Sylvester R, Gonzenbach R, von Wyl V, Haag C
JMIR Mhealth Uhealth
. 2023 Dec;
11:e50729.
PMID: 38064263
Background: Physical activity is central to maintaining the quality of life for patients with complex chronic conditions and is thus at the core of neurorehabilitation. However, maintaining activity improvements in...
8.
Patt N, Kupjetz M, Kool J, Hersche R, Oberste M, Joisten N, et al.
Mult Scler Relat Disord
. 2023 Aug;
78:104929.
PMID: 37579643
Background: Fatigue is one of the most frequent symptoms in persons with multiple sclerosis (pwMS) and impacts health-related quality of life (HRQoL). A multidisciplinary rehabilitation approach is recommended for the...
9.
Schlagheck M, Bansi J, Wenzel C, Kuzdas-Sallaberger M, Kiesl D, Gonzenbach R, et al.
Eur J Neurol
. 2023 May;
30(9):2726-2735.
PMID: 37209371
Background And Purpose: Valid measurements of cardiorespiratory fitness in persons with multiple sclerosis (pwMS) are essential during inpatient rehabilitation for a precise evaluation of the current health status, for defining...
10.
Kupjetz M, Joisten N, Rademacher A, Gonzenbach R, Bansi J, Zimmer P
BMC Neurol
. 2023 Apr;
23(1):162.
PMID: 37087424
Background: Primary progressive multiple sclerosis (PPMS) is the least prevalent multiple sclerosis (MS) phenotype. For persons with PPMS (pwPPMS), pharmacological treatment options are limited. As a complementary non-pharmacological treatment, endurance...